Evolution of the hypervariable region of hepatitis C virus

Journal of Viral Hepatitis

Volumn 6, Issue SUPPL. 1, 1999, Pages 41-46

  Smith, D B ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Evolution; Function; Hepatitis C virus; Hypervariable region; Persistence

Indexed keywords

VIRUS PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; CHRONIC HEPATITIS; CONFERENCE PAPER; EVOLUTION; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION;

AMINO ACID SEQUENCE; AMINO ACIDS; HEPACIVIRUS; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 0032809666     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00010.x     Document Type: Article

References (51)

1. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392-3396.
2. Okamoto H, Kojima M, Okada S-I et al. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virol 1992; 190: 894-899.
3. Abe K, Inchauspe G, Fujisawa K. Genomic characterisation and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic on non-A, non-B hepatitis in Japan. J Gen Virol 1992; 73: 2725-2729.
4. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol 1997; 71: 4123-4127.
5. McAllister J, Casino C, Davidson F et al. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998; 72: 4893-4905.
6. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-3472.
7. Kato N, Ootsuyama Y, Sekiya H et al. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 4776-4784.
8. Sekiya H, Kato N, Ootsuyama Y et al. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer 1994; 57: 664-670.
9. Scarselli E, Cerino A, Esposito G et al. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995; 69: 4407-1412.
10. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2 NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 1072-1075.
11. Odeberg J, Yun ZB, Sonnerborg A et al. Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis 1997; 175: 938-943.
12. Booth JCL, Kumar U, Webster D, Monjardino J, Thomas HC. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatol 1998; 27: 223-227.
13. Sherman KE, Andreatta C, Obrien J, Gutierrez A, Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain. Hepatol 1996; 23: 688-694.
14. Toyoda H, Fukuda Y, Koyama Y et al. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 1997; 26: 975-982.
15. Rosa D, Campagnoli S, Moretto C et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996; 93: 1759-1763.
16. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virol 1995; 208: 653-661.
17. Farci P, Shimoda A, Wong D et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996; 93: 15394-15399.
18. Casino C, McAllister J, Davidson F et al. Variation of hepatitis C virus following serial transmission: multiple mechanisms of diversification of the hypervariable region and evidence for convergent evolution. J Gen Virol 1999; 80: 717-725.
19. Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 1997; 236: 44-49.
20. Smith DB, Simmonds P. Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 1997; 45: 238-246.
21. Smith DB, Pathirana S, Davidson F et al. The origin of hepatitis C virus genotypes. J Gen Virol 1997; 78: 321-328.
22. Kato N, Ootsuyama Y, Tanaka T et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107-123.
23. Hohne M, Schreier E, Roggendorf M. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol 1994; 137: 25-34.
24. Odeberg J, Yun ZB, Sonnerborg A, Uhlen M, Lundeberg J. Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. J Clin Microbiol 1995; 33: 1870-1874.
25. Kumar U, Brown J, Monjardino J, Thomas HC. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993; 167: 726-730.
26. Higashi Y, Kakumu S, Yoshioka K et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virol 1993; 197: 659-668.
27. Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Quasispecies of Hepatitis C virus and Genetic Drift of the Hypervariable region in Chronic Type C hepatitis. J Infect Dis 1995; 172: 261-264.
28. Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virol 1994; 204: 665-672.
29. Vandoorn LJ, Capriles I, Maertens G et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995; 69: 773-778.
30. Wyatt CA, Andrus L, Brotman B et al. Immunity in chimpanzees chronically infected with hepatitis C virus: Role of minor quasispecies in reinfection. J Virol 1998; 72: 1725-1730.
31. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus corrleates with responsiveness to interferon therapy in viraemic patients. Hepatol 1992; 16: 619-624.
32. Polyak SJ, McArdle S, Liu SL et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 1998; 72: 4288-4296.
33. Manzin A, Solforosi L, Petrelli E et al. Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol 1998; 72: 6271-6276.
34. Jarvis LM, Watson HG, McOmish F et al. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994; 170: 1018-1022.
35. Learn GH, Korber BTM, Foley B et al. Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol 1996; 70: 5720-5730.
36. Aiyama T, Yoshioka K, Okumura A et al. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C. Relationship to antibody response against hypervariable region genome. Hepatol 1996; 24: 1346-1350.
37. Smith DB, McAllister J, Casino C, Simmonds P. Virus 'quasispecies': Making a mountain out of a molehill? J Gen Virol 1997; 78: 1511-1519.
38. Taniguchi S, Okamoto H, Sakamoto M et al. A structurally flexible and antigenically variable n-terminal domain of the hepatitis C virus E2/NS1 protein - implication for an escape from antibody. Viol 1993; 195: 29 7-301.
39. Nakazawa T, Kato N, Ootsuyama Y et al. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. Int J Cancer 1994; 56: 204-207.
40. Kurosaki M, Enomoto N, Marumo F, Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virol 1994; 205: 161-169.
41. Lerat H, Berby F, Trabaud MA et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97: 845-851.
42. Mellor J, Haydon GH, Blair C, Livingstone WJ, Simmonds P. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol 1998; 79: 705-714.
43. Shimizu YK, Igarashi H, Kanematu T et al. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997; 71: 5769-5773.
44. Saito S, Kato N, Hijikata M et al. Comparison of hypervariable regions (HVR1 and HVR2) in positive-and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatoccllular carcinoma. Int J Cancer 1996; 67: 199-203.
45. Maggi F, Fornai C, Vatteroni ML et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997; 78: 1521-1525.
46. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998; 72: 1640-1646.
47. Kato N, Sekiya H, Ootsuyama Y et al. Humoral immune response to hypervariable region-1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923-3930.
48. Yoshioka K, Higashi Y, Tanaka K et al. Deficiency of antibody response to hypervariable region of hepatitis C virus in patients with chronic hepatitis C. J Hepatol 1996; 24: 649-657.
49. Muerhoff AS, Smith DB, Leary TP et al. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997; 71: 6501-6508.
50. Nakao H, Okamoto H, Fukuda M et al. Mutation rate of GB virus C hepatitis G virus over the entire genome and in subgenomic regions. Virol 1997; 233: 43-50.
51. Ina Y. ODEN: a program package for molecular evolutionary analysis and database search of DNA and amino acid sequences. Comput Appl Biosci 1994; 10: 11-12.